Key Q3 2025 updates on class action litigation, expert evidence standards, arbitration waivers, and auto insurance valuation disputes impacting U.S. insurers and legal strategies.

Recent Supreme Court procedural rulings lower barriers for corporate lawsuits, enabling strategic venue choices and expanded standing, impacting environmental and FDA regulatory challenges in U.S. federal courts.